Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, June 29, 2018

Growth hormone releasing peptide‐6 acts as a survival factor in glutamate‐induced excitotoxicity

With ANY BRAINS AT ALL,  our stroke leaders would recognize this as a possible solution to the excitotoxicity problem of the neuronal cascade of death. 
But nothing will occur because they can't add 1+1.
https://onlinelibrary.wiley.com/doi/full/10.1111/j.1471-4159.2006.04122.x 
 Address correspondence and reprint requests to Dr Laura M. Frago, Department of Endocrinology, Hospital Infantil Universitario Niño Jesús, Avenida Menéndez Pelayo 65, 28009 Madrid, Spain
E‐mail: laura.frago@uam.es

Abstract

Chronic systemic treatment given to adult male rats with growth hormone releasing peptide‐6, an agonist of the ghrelin receptor, increases insulin‐like growth factor I levels in various brain regions, including the hypothalamus and cerebellum. Furthermore, intracellular signalling cascades normally associated with anti‐apoptotic actions are activated in the same areas and are coincident with decreased basal cell death. Because abnormally high concentrations of glutamate can lead to overexcitation of neurones leading to cell damage and/or death, we investigated whether administration of growth hormone releasing peptide‐6 attenuates monosodium glutamate‐induced apoptosis in the rat hypothalamus and cerebellum. Glutamate increased activation of caspase 9 followed by cleavage of caspase 7, which in turn fragmented poly(ADP‐ribose) polymerase, terminating in cell death in both the hypothalamus and cerebellum. Growth hormone releasing peptide‐6 reversed glutamate‐induced cell death by decreasing activation of caspases 9 and 7 and poly(ADP‐ribose) polymerase fragmentation. These results provide a better understanding of the neuroprotective role of growth hormone secretagogues and the mechanisms involved.

No comments:

Post a Comment